1. Home
  2. TNON vs PRFX Comparison

TNON vs PRFX Comparison

Compare TNON & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

BUY

Current Price

$2.27

Market Cap

2.8M

Sector

Health Care

ML Signal

BUY

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$0.71

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNON
PRFX
Founded
2012
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TNON
PRFX
Price
$2.27
$0.71
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $44.38
N/A
AVG Volume (30 Days)
★ 255.9K
32.4K
Earning Date
11-12-2026
09-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
N/A
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
N/A
Revenue This Year
$46.86
N/A
Revenue Next Year
$63.99
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$2.40
$0.58
52 Week High
$45.50
$5.39

Technical Indicators

Market Signals
Indicator
TNON
PRFX
Relative Strength Index (RSI) 34.65 34.01
Support Level N/A $0.58
Resistance Level $4.18 $1.28
Average True Range (ATR) 0.22 0.05
MACD -0.01 -0.01
Stochastic Oscillator 1.94 20.53

Price Performance

Historical Comparison
TNON
PRFX

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: